title: Cutaneous infections due to opportunistic molds: uncommon presentations.
abstract: Molds are quite more often suspected as pathogens by the public than by the medical care community. Molds may, however, cause serious medical problems, and mold infections can develop incognito. Among the mycoses caused by opportunistic molds, alternariosis and fusariosis together with aspergillosis are of particular importance. They are more common than other groups with pathological characteristics. The aim of our presentation is to demonstrate the important role of common molds as causative agents in skin and ear infections. The clinical picture, etiology and pathogenesis, diagnosis and treatment, and course and prognosis of cutaneous infections will be given. The spectrum of clinical symptoms ranges from eczemalike lesions to chronic erythematous, verrucous lesions of the skin or multiple acute infiltrations of the dermis, occasionally forming abscesses. The mycologic direct preparation of the specimens, particularly with optical brighteners, and a histological examination of a skin biopsy are strongly recommended. The outbreak of cutaneous infections is triggered by weakened host defense mechanisms. A review of the literature regarding immunosuppressed and immunocompetent patients will be given.
authors.affiliation: Institute of Laboratory Medicine, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany. vennewald-ir@khdf.de
authors.forename: Irina
authors.initials: I
authors.lastname: Vennewald
authors.forename: Uwe
authors.initials: U
authors.lastname: Wollina
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D003881:Dermatomycoses / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D005260:Female; D005658:Fungi / Q000145:classification / Q000472:pathogenicity*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D000935:Antifungal Agents